CollabRx, Inc. was a company that offered cloud-based expert systems for selecting clinical treatments for molecular diseases such as cancer. Its technology revolved around dynamically updated molecular disease models that form the basis of the expert systems. One of the challenges evolving from the recent explosion in biological information is to distill actionable clinically relevant therapy approaches from the vast amount of data available. The
knowledgebase
A knowledge base (KB) is a technology used to store complex structured and unstructured information used by a computer system. The initial use of the term was in connection with expert systems, which were the first knowledge-based systems.
Ori ...
s that inform the models were updated by a large network of advisors from academic and medical institutions.
Access to the expert systems was offered under
software-as-a-service
Software as a service (SaaS ) is a software licensing and delivery model in which software is licensed on a subscription basis and is centrally hosted. SaaS is also known as "on-demand software" and Web-based/Web-hosted software.
SaaS is cons ...
contracts. A major user of the technology was expected to be DNA testing laboratories which hope to translate patient-specific genetic characterization to patient-specific clinical treatment advice for
molecular diseases.
History
CollabRx was founded in 2008 by computer scientist Jeff Shrager, Silicon Valley internet pioneer
Jay Martin Tenenbaum
Jay Martin "Marty" Tenenbaum is an American computer scientist and entrepreneur. He is noted for his early work in artificial intelligence and as an Internet commerce pioneer.
Biography
Tenenbaum attended the Massachusetts Institute of Technolog ...
, and mathematician Raphael Lehrer.
In July 2012, Tegal Corporation acquired CollabRx.
In October 2015, CollabRx was merged with Medytox solutions.
References
Equipment semiconductor companies
Companies formerly listed on the Nasdaq
Defunct software companies of the United States
{{US-software-company-stub